title: Measurement of salivary aldosterone: validation by low-dose ACTH test and gender differences.
abstract: The aim of the present study was to validate the feasibility of measurement of the salivary aldosterone concentrations by performing a low-dose adrenocorticotropic hormone (ACTH) test. Moreover, the presence of gender differences in salivary aldosterone, considering the phase of the menstrual cycle in women, was verified. The sample consisted of 107 volunteers (60 men, 21 women in the follicular phase and 26 women in the luteal phase of the menstrual cycle). Saliva samples were taken by the subjects themselves around 08:00 AM, at least 60 min after awaking. A separate group of female subjects in the follicular phase underwent low-dose ACTH test (1µg synthetic ACTH i.v.) performed at 08:30 AM with blood and saliva sampling every 30 min for 120 min. Modification of the commercial aldosterone radioimmunoassay methodology for the salivary aldosterone measurement was performed. Salivary aldosterone concentrations rose in response to low-dose ACTH test and positive significant correlation in aldosterone concentrations between plasma and saliva was found. The results showed that women in the luteal phase of the menstrual cycle exhibited significantly higher morning concentrations in salivary aldosterone than men and women in the follicular phase. This study clearly demonstrates suitability of measurement of salivary aldosterone concentrations in the low-dose ACTH test and reveals gender differences in salivary aldosterone levels. The results show high validity of the presented method and its usefulness for assessment of the aldosterone concentrations in saliva.
authors.forename: N
authors.initials: N
authors.lastname: Hlavacova
authors.forename: J
authors.initials: J
authors.lastname: Kerlik
authors.forename: Z
authors.initials: Z
authors.lastname: Radikova
authors.forename: L
authors.initials: L
authors.lastname: Izakova
authors.forename: D
authors.initials: D
authors.lastname: Jezova
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage*; D000328:Adult; D000450:Aldosterone / Q000378:metabolism*; D002624:Chemistry, Clinical / Q000379:methods / Q000592:standards*; D002940:Circadian Rhythm / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005498:Follicular Phase / Q000378:metabolism*; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008183:Luteal Phase / Q000378:metabolism*; D008297:Male; D015203:Reproducibility of Results; D012463:Saliva / Q000378:metabolism; D012727:Sex Characteristics; D055815:Young Adult
chemical_list: D006728:Hormones; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone